Related Experiment Video
Updated: Jul 6, 2026
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Chemotherapy and cerebrovascular disease
M Saynak1, R Cosar-Alas, V Yurut-Caloglu
1Department of Radiation Oncology, Trakya University, Faculty of Medicine, Edirne, Turkey. mertsaynak@gmail.com
Summary
Cancer patients frequently experience cerebrovascular disease, often triggered by treatments like chemotherapy. Understanding these risks is crucial for planning effective cancer care and improving patient outcomes.
Area of Science:
- Oncology
- Neurology
- Hematology
Background:
- Cerebrovascular disease is a significant concern in cancer patients.
- Certain tumors increase the risk of cerebrovascular complications.
- Cancer treatments, including chemotherapy, can provoke cerebrovascular events.
Purpose of the Study:
- To review the relationship between cancer treatments and cerebrovascular complications.
- To highlight the challenges in differentiating treatment-induced from cancer-related strokes.
- To emphasize the importance of considering cerebrovascular risks in cancer treatment planning.
Main Methods:
- Review of existing literature, including case reports on chemotherapy-related thrombosis.
- Analysis of mechanisms linking antineoplastic agents to stroke (e.g., endothelium toxicity, coagulation abnormalities).
- Discussion of chemotherapy's impact on the hemostatic system, potentially causing brain hemorrhages.
Main Results:
- Several anticancer agents (L-asparaginase, cisplatin, 5-fluorouracil, methotrexate) are associated with stroke.
- Mechanisms include direct endothelial toxicity and disruption of coagulation factors.
- Chemotherapy can also lead to brain hemorrhages due to effects on hemostasis.
Conclusions:
- Treatment-induced cerebrovascular disorders negatively impact cancer patient quality of life and survival.
- Distinguishing between cancer-related and treatment-related strokes is clinically challenging.
- Integrating cerebrovascular risk assessment into cancer treatment strategies is essential.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...